查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049748

關節內粘稠補充療法市場：按類型、年齡層、銷售管道、應用、最終用途和地區分類（2026-2034 年）

Viscosupplementation Market by Type, Age Group, Distribution Channel, Application, End Use, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球關節內粘稠補充療法市場規模達51億美元。展望未來，IMARC Group預測，該市場在2026年至2034年間將以6.77%的複合年成長率成長，到2034年達到94億美元。骨質疏鬆症和骨關節炎（OA）盛行率的不斷上升，以及消費者對微創、非手術治療偏好的轉變，是推動市場成長的主要因素。

關節內粘稠補充療法是一種微創醫療程序，將一種稱為外源性透明質酸（HA）衍生物的凝膠狀液體直接注射到患者的膝關節內。這種衍生物起到潤滑劑的作用，使骨骼能夠順暢地相互運動，減輕炎症，並起到緩衝關節壓力的作用。關節內粘稠補充療法可以減少運動時的摩擦，增強滑液的緩衝作用，緩解劇烈疼痛，並增加關節的活動範圍。此外，透過恢復滑液的流變特性，它還具有機械作用、鎮痛作用、抗發炎作用和軟骨保護作用。因此，關節內粘稠補充療法被廣泛用於治療膝關節、髖關節和手部的骨關節炎。目前，本產品主要分為中分子量、低分子量和高分子量三種類型。

關節內粘稠補充療法市場的發展趨勢：

骨質疏鬆症和骨關節炎（OA）盛行率的不斷上升是市場成長的主要驅動力。同時，消費者對微創、非手術治療方法的偏好日益增強，推動了皮質類固醇和關節內粘稠補充療法在關節疼痛管理領域的廣泛應用，這也是市場成長要素。消費者對非手術治療諸多益處的認知不斷提高，例如無需住院、費用更低、併發症更少以及臨床療效和康復率更高，也進一步促進了這一趨勢。此外，政府為新藥上市和不同給藥途徑的開發提供的有利政策，以及各製藥公司的大量投資，都為市場成長提供了支持。同時，為包括關節、韌帶、肌肉、脊椎和神經在內的身體各部位的手術和非手術問題提供強化護理的門診手術中心（ACS）的出現，也促進了市場成長。最後，採用玻尿酸的開放標籤單次注射療法的推出也是推動市場成長的因素之一。此外，有利的醫療保險報銷政策、慢性疾病的老年人口不斷成長、慢性殘疾人數增加、主要公司之間的合作與夥伴關係，以及醫療領域持續不斷的研發活動，都對市場成長產生了積極影響。

本報告解答的主要問題：

  • 全球關節內粘稠補充療法市場迄今為止的發展趨勢是什麼？預計未來幾年將如何發展？
  • 全球關節內粘稠補充療法市場的促進因素、阻礙因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪個國家是關節內粘稠補充療法最具吸引力的市場？
  • 按類型分類的市場組成是什麼？
  • 按年齡層分類的市場組成是什麼？
  • 按分銷管道分類的市場區隔如何？
  • 按應用領域分類的市場區隔如何？
  • 依最終用途分類的市場區隔如何？
  • 全球關節內粘稠補充療法市場的競爭格局如何？
  • 全球關節內粘稠補充療法市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球關節內粘稠補充療法市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 單次注射
  • 三次注射
  • 五針

第7章 市場區隔：依年齡層別分類

  • 成人
  • 老年人

第8章 市場區隔：依分銷通路分類

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章 市場區隔：依應用領域分類

  • 膝關節骨關節炎
  • 髖關節骨關節炎
  • 手部骨關節炎
  • 其他

第10章 市場區隔：依最終用途分類

  • 醫院
  • 整形外科診所
  • 其他

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第12章：促進、抑制與機遇

第13章：價值鏈分析

第14章：波特五力分析

第15章：價格分析

第16章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Anika Therapeutics Inc.
    • Aptissen SA
    • Bioventus LLC
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici SpA
    • Johnson & Johnson
    • LG Chem Ltd.
    • OrthogenRx Inc.（Avanos Medical Inc.）
    • Sanofi SA
    • Seikagaku Corporation
    • Virchow Biotech Private Limited
    • Zimmer Biomet
    • Zuventus HealthCare Ltd.（Emcure Pharmaceuticals Limited）
Product Code: SR112026A6931

The global viscosupplementation market size reached USD 5.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.77% during 2026-2034.The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting consumer inclination toward minimally invasive non-surgical treatments represent some of the key factors driving the market.

Viscosupplementation represents a minimally invasive medical procedure wherein intraarticular injection comprising gel-like fluid known as exogenous hydraulic acid (HA) derivatives are directly administered into the knee joints of the patient. It acts as a lubricant, which enables bones to move smoothly over each other, lowers inflammation, and performs as a shock absorber for joint loads. Viscosupplementation reduces the friction during the movements, assists the synovial fluids in creating more cushion, eliminates severe pain, and enhances the range of movements or motions of the joint. Apart from this, it restores the rheological properties of the synovial fluids, which produce mechanical, analgesic, anti-inflammatory, and chondroprotective effects. As a result, viscosupplementation is extensively utilized in the treatment of knee, hip, and hand osteoarthritis. Currently, it is mainly available in intermediate, low, and high molecular weights.

Viscosupplementation Market Trends:

The increasing prevalence of osteoporosis and osteoarthritis (OA) represents one of the key factors driving the market growth. In line with this, the shifting consumer inclination toward the minimally invasive non-surgical treatment options has facilitated the widespread adoption of viscosupplementation in the healthcare sector for corticosteroids and joint pain management. This, in turn, is acting as another major growth-inducing factor. This is further influenced by the growing consumer awareness regarding the multiple benefits of non-surgical treatments, including no hospitalization, fewer expenses, minimal complications, and better clinical outcomes and recovery rates. Additionally, the favorable government initiatives and significant investments by various pharmaceutical companies to launch novel drugs and different routes of administrations is supporting the market growth. Moreover, the emergence of ambulatory surgical centers (ACS) that offer intensive treatment to resolve surgical and non-surgical problems in various body parts, such as joints, ligaments, muscle, spine, and nerves, is favoring the market growth. Furthermore, the introduction of open-label single-injections with hydraulic acid is propelling the market growth. Apart from this, favorable health insurance reimbursement policies, the rising geriatric population, which is susceptible to chronic ailments, increasing number of individuals with chronic disability, collaborations and partnership among the key players, and continuous research and development (R&D) activities in the field of medical sciences are positively impacting the market growth.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the global viscosupplementation market, along with forecasts at the global, regional, and country level from 2026-2034. Our report has categorized the market based on type, age group, distribution channel, application and end use.

Type Insights:

  • Single Injection
  • Three Injection
  • Five Injection

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the type. This includes single, three and five injection. According to the report, single injection represented the largest segment.

Age Group Insights:

  • Adults
  • Geriatrics

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Application Insights:

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Others

End Use Insights:

  • Hospitals
  • Orthopedic Clinics
  • Others

The report has also provided a detailed breakup and analysis of viscosupplementation market based on the end use. This includes hospitals, orthopedic clinics, and others. According to the report, orthopedic clinics represented the largest segment.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, the North America was the largest market for viscosupplementation. Some of the factors driving the North America viscosupplementation market included the rising geriatric population and the affordable health insurance reimbursement policies.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global viscosupplementation market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Anika Therapeutics Inc., Aptissen S.A., Bioventus LLC, Ferring Pharmaceuticals, Fidia Farmaceutici S.p.A., Johnson & Johnson, LG Chem Ltd., OrthogenRx Inc. (Avanos Medical Inc.), Sanofi S.A., Seikagaku Corporation, Virchow Biotech Private Limited, Zimmer Biomet, Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited), etc.

Key Questions Answered in This Report:

  • How has the global viscosupplementation market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global viscosupplementation market?
  • What are the key regional markets?
  • Which countries represent the most attractive viscosupplementation markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the age group?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What is the competitive structure of the global viscosupplementation market?
  • Who are the key players/companies in the global viscosupplementation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Viscosupplementation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single Injection
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Three Injection
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Five Injection
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Age Group

  • 7.1 Adults
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Geriatrics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Knee Osteoarthritis
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hip Osteoarthritis
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hand Osteoarthritis
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End Use

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Orthopedic Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Anika Therapeutics Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Aptissen S.A.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 Bioventus LLC
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Ferring Pharmaceuticals
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Fidia Farmaceutici S.p.A.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Johnson & Johnson
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 LG Chem Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 OrthogenRx Inc. (Avanos Medical Inc.)
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Sanofi S.A.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Seikagaku Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Virchow Biotech Private Limited
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zimmer Biomet
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Zuventus HealthCare Ltd. (Emcure Pharmaceuticals Limited)
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio

List of Figures

  • Figure 1: Global: Viscosupplementation Market: Major Drivers and Challenges
  • Figure 2: Global: Viscosupplementation Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Viscosupplementation Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Viscosupplementation Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Viscosupplementation Market: Breakup by Age Group (in %), 2025
  • Figure 6: Global: Viscosupplementation Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Viscosupplementation Market: Breakup by Application (in %), 2025
  • Figure 8: Global: Viscosupplementation Market: Breakup by End Use (in %), 2025
  • Figure 9: Global: Viscosupplementation Market: Breakup by Region (in %), 2025
  • Figure 10: Global: Viscosupplementation (Single Injection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Viscosupplementation (Single Injection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Viscosupplementation (Three Injection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Viscosupplementation (Three Injection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Viscosupplementation (Five Injection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Viscosupplementation (Five Injection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Viscosupplementation (Adults) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Viscosupplementation (Adults) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Viscosupplementation (Geriatrics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Viscosupplementation (Geriatrics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Viscosupplementation (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Viscosupplementation (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Viscosupplementation (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Viscosupplementation (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Viscosupplementation (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Viscosupplementation (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Viscosupplementation (Knee Osteoarthritis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Viscosupplementation (Knee Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Viscosupplementation (Hip Osteoarthritis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Viscosupplementation (Hip Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Viscosupplementation (Hand Osteoarthritis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Viscosupplementation (Hand Osteoarthritis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Viscosupplementation (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Viscosupplementation (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Viscosupplementation (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Viscosupplementation (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Viscosupplementation (Orthopedic Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Viscosupplementation (Orthopedic Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Viscosupplementation (Other End Uses) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Viscosupplementation (Other End Uses) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: North America: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: North America: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: United States: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: United States: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Canada: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Canada: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Asia-Pacific: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Asia-Pacific: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: China: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: China: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Japan: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Japan: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: India: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: India: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: South Korea: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: South Korea: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Australia: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Australia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Indonesia: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Indonesia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Europe: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Europe: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Germany: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Germany: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: France: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: France: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United Kingdom: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United Kingdom: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Italy: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Italy: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Spain: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Spain: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Russia: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Russia: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Latin America: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Latin America: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Brazil: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Brazil: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Mexico: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Mexico: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Others: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Others: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Middle East and Africa: Viscosupplementation Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Middle East and Africa: Viscosupplementation Market: Breakup by Country (in %), 2025
  • Figure 88: Middle East and Africa: Viscosupplementation Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Global: Viscosupplementation Industry: Drivers, Restraints, and Opportunities
  • Figure 90: Global: Viscosupplementation Industry: Value Chain Analysis
  • Figure 91: Global: Viscosupplementation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Viscosupplementation Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: Viscosupplementation Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Viscosupplementation Market Forecast: Breakup by Age Group (in Million USD), 2026-2034
  • Table 4: Global: Viscosupplementation Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Viscosupplementation Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Viscosupplementation Market Forecast: Breakup by End Use (in Million USD), 2026-2034
  • Table 7: Global: Viscosupplementation Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Viscosupplementation Market: Competitive Structure
  • Table 9: Global: Viscosupplementation Market: Key Players